icosapent ethyl

FDA Drug Profile — icosapent ethyl, ICOSAPENT ETHYL, Vascepa

icosapent ethyl is listed in the FDA National Drug Code directory with 28 NDC codes, marketed under brand names including icosapent ethyl, ICOSAPENT ETHYL, Vascepa. Available dosage forms: capsule, capsule, liquid filled.

Drug Details

Generic Name
icosapent ethyl
Brand Names
icosapent ethyl, ICOSAPENT ETHYL, Vascepa
Application Number
ANDA217656
Sponsor
Softgel Healthcare Private Limited
NDC Codes
28
Dosage Forms
CAPSULE, CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients
ICOSAPENT ETHYL

Indications and Usage

1 INDICATIONS AND USAGE Icosapent ethyl capsules are indicated: • as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Limitations of Use: The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. Icosapent ethyl capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated: as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. ( 1 ) Limitations of Use: The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. ( 1 )